SCHEMBL5720524

SCHEMBL5720524

BrC(Br)(Br)c1cc2ccccc2cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.50
CYP2A6 P11509 2/20 0.50
PDPK1 O15530 1/20 0.50
NPC1 O15118 2/20 0.41
PLAU P00749 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SSTR4 P31391 1/20 0.39
RAB9A P51151 1/20 0.39
CHEK1 O14757 1/20 0.39
HTR3A P46098 1/20 0.38
KDM4E B2RXH2 2/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
BTK Q06187 1/20 0.37
NQO2 P16083 1/20 0.36
MTOR P42345 1/20 0.36
GPR3 P46089 1/20 0.35
MAPT P10636 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31391610 0.80 CYP1A2 (0.48) CYP1A2CYP2A6PDPK1NPC1PLAU
SCHEMBL762341 0.80 CYP1A2 (0.54) CYP1A2CYP2A6PDPK1NPC1PLAU
SCHEMBL5720250 0.80 CYP1A2 (0.48) CYP1A2CYP2A6PDPK1NPC1PLAU
SCHEMBL5660630 0.80 CYP1A2 (0.48) CYP1A2CYP2A6PDPK1NPC1PLAU
SCHEMBL4372845 0.77 CYP1A2 (0.50) CYP1A2CYP2A6PDPK1NPC1PLAU
SCHEMBL26042691 0.77 CYP1A2 (0.50) CYP1A2CYP2A6PDPK1NPC1PLAU
SCHEMBL11924585 0.74 CYP1A2 (0.47) CYP1A2CYP2A6PDPK1NPC1PLAU
SCHEMBL4367342 0.74 PDPK1 (0.47) CYP1A2CYP2A6PDPK1NPC1PLAU
SCHEMBL30930616 0.71 CYP2A6 (0.54) CYP1A2CYP2A6PDPK1NPC1PLAU
SCHEMBL427159 0.71 CYP2A6 (0.54) CYP1A2CYP2A6PDPK1NPC1PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12612548-B2 Method for producing inorganic fluoride luminescent material NICHIA CORPORATION (JP) 2026-04-28 US disclosed
US-20230220275-A1 METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-07-13 US disclosed
US-20230142294-A1 PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-05-11 US disclosed
WO-2021241376-A1 METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL 日亜化学工業株式会社 2021-12-02 WO disclosed
WO-2021241375-A1 PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL 日亜化学工業株式会社 2021-12-02 WO disclosed
EP-1072576-B1 FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF MITSUI CHEMICALS INC (JP) 2006-08-02 EP disclosed
US-6417361-B1 HYDROGEN FLUORIDE AND N,N'-DIALKYLCYCLIC UREA COMPOUND MITSUI CHEMICALS, INC. (JP) 2002-07-09 US disclosed
EP-1072576-A1 FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2001-01-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612548-B2 Method for producing inorganic fluoride luminescent material FLNA, F7, NPM1 CYP1A2 1949/4885CYP2A6 4042/4885PDPK1 368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.